I08.8 Insurance Policy Changes

ICD-10 I08.8 is officially defined as "Other rheumatic multiple valve diseases." code I08.8 is referenced in 3 tracked payer policy changes from Aetna and Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code I08.8 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Aug 14, 2026Medium impact
Balloon Valvuloplasty (CPB 0477, reviewed 2026-07-17)
Balloon valvuloplasty is medically necessary for severe rheumatic mitral stenosis, severe aortic stenosis, and pulmonary valve stenosis when the listed criteria are met. For mitral stenosis with favorable valve anatomy, the criteria include a cumulative echocardiographic score of 8 or less. Balloon dilation for all other indications not listed is experimental, investigational, or unproven, including balloon aortic valvuloplasty used to select transcatheter heart valve size and percutaneous balloon valvuloplasty for bioprosthetic tricuspid valve stenosis.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Transcatheter Mitral Valve Repair or Replacement
Transcatheter mitral valve repair with an FDA-approved device, such as MitraClip or PASCAL, may be considered medically necessary for individuals with symptomatic primary mitral regurgitation who are at prohibitive risk for open surgery, and for individuals with heart failure and moderate-to-severe or severe symptomatic secondary mitral regurgitation despite maximally tolerated guideline-directed medical therapy. Transcatheter mitral valve-in-valve replacement with an FDA-approved device is considered medically necessary when a surgical bioprosthetic mitral valve has failed, the individual has NYHA class II, III, or IV heart failure symptoms, and the individual is not an operable candidate for open surgery or is at intermediate to prohibitive surgical risk, as documented by cardiovascular specialists. All other transcatheter mitral valve repair is considered investigational.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Transcatheter Aortic Valve Implantation for Aortic Stenosis
Transcatheter aortic valve replacement with an FDA-approved transcatheter heart valve system may be considered medically necessary for individuals with native valve aortic stenosis who have severe aortic stenosis with a calcified aortic valve, New York Heart Association Class II, III or IV heart failure symptoms, and no unicuspid or bicuspid aortic valves. Valve-in-valve replacement of a failed surgical bioprosthetic aortic valve may be considered medically necessary when the individual meets the policy's surgical risk criteria documented by at least 2 cardiovascular specialists, and use of a cerebral embolic protection device (e.g., Sentinel) during these procedures is considered investigational. The 08/13/2025 update changed the policy description regarding devices, and the policy statements are unchanged.

Watch I08.8

Get one email when a payer policy names I08.8, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code I08.8?

There are 3 tracked policy changes affecting code I08.8, including updates from Aetna, Blue Cross & Blue Shield of Mississippi. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code I08.8?

Payers that have issued tracked updates for code I08.8 include: Aetna, Blue Cross & Blue Shield of Mississippi.

How do I get notified when code I08.8 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code I08.8. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code I08.8?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Balloon Valvuloplasty (CPB 0477, reviewed 2026-07-17)

Transcatheter Mitral Valve Repair or Replacement

Transcatheter Aortic Valve Implantation for Aortic Stenosis

What insurance policy changes affect code I08.8?

Which payers have updated policy for code I08.8?

How do I get notified when code I08.8 policy changes?

Why do payers change policies for code I08.8?